| Year |
Citation |
Score |
| 2024 |
Facal CL, Fernández Bessone I, Muñiz JA, Pereyra AE, Pedroncini O, Páez-Paz I, Clerici-Delville R, Arnaiz C, Urrutia L, Falasco G, Argañaraz CV, Saez T, Marin-Burgin A, Soiza-Reilly M, Falzone T, et al. Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 38310353 DOI: 10.1016/j.ymthe.2024.01.033 |
0.737 |
|
| 2022 |
Fernandez Bessone I, Navarro J, Martinez E, Karmirian K, Holubiec M, Alloatti M, Goto-Silva L, Arnaiz Yepez C, Martins-de-Souza D, Nascimento JM, Bruno L, Saez TM, Rehen SK, Falzone TL. DYRK1A regulates the bidirectional axonal transport of APP in human-derived neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 35803734 DOI: 10.1523/JNEUROSCI.2551-21.2022 |
0.801 |
|
| 2020 |
Saez TM, Fernandez Bessone I, Rodriguez MS, Alloatti M, Otero MG, Cromberg LE, Pozo Devoto VM, Oubiña G, Sosa L, Buffone MG, Gelman DM, Falzone TL. Kinesin-1-mediated axonal transport of CB1 receptors is required for cannabinoid-dependent axonal growth and guidance. Development (Cambridge, England). PMID 34004816 DOI: 10.1242/dev.184069 |
0.818 |
|
| 2020 |
Saez TM, Fernandez Bessone I, Rodriguez MS, Alloatti M, Otero MG, Cromberg LE, Pozo Devoto VM, Oubiña G, Sosa L, Buffone MG, Gelman DM, Falzone TL. Kinesin-1-mediated axonal transport of CB1 receptors is required for cannabinoid-dependent axonal growth and guidance. Development (Cambridge, England). PMID 32265198 DOI: 10.1242/Dev.184069 |
0.658 |
|
| 2018 |
Otero MG, Fernandez Bessone I, Hallberg AE, Cromberg LE, De Rossi MC, Saez TM, Levi V, Almenar-Queralt A, Falzone TL. Proteasome stress leads to APP axonal transport defects by promoting its amyloidogenic processing in lysosomes. Journal of Cell Science. 131. PMID 29724915 DOI: 10.1242/Jcs.214536 |
0.709 |
|
| 2017 |
Pozo Devoto VM, Dimopoulos N, Alloatti M, Pardi MB, Saez TM, Otero MG, Cromberg LE, Marín-Burgin A, Scassa ME, Stokin GB, Schinder AF, Sevlever G, Falzone TL. αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease. Scientific Reports. 7: 5042. PMID 28698628 DOI: 10.1038/S41598-017-05334-9 |
0.682 |
|
| 2017 |
Alloatti M, Bessone IF, Hallberg A, Otero MG, Saez T, Rehen S, Falzone T. [P2-137]: PROTEASOME ACTIVITY INVOLVED IN THE MODIFICATIONS OF APP METABOLISM AND THE INDUCTION OF ALZHEIMER PATHOLOGY Alzheimer's & Dementia. 13: P658-P658. DOI: 10.1016/J.Jalz.2017.06.787 |
0.747 |
|
| 2015 |
Caltana L, Saez TM, Aronne MP, Brusco A. Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice. Journal of Neurochemistry. 135: 616-29. PMID 26296704 DOI: 10.1111/Jnc.13288 |
0.335 |
|
| 2009 |
Katunar MR, Saez T, Brusco A, Antonelli MC. Immunocytochemical expression of dopamine-related transcription factors Pitx3 and Nurr1 in prenatally stressed adult rats. Journal of Neuroscience Research. 87: 1014-22. PMID 18951485 DOI: 10.1002/Jnr.21911 |
0.302 |
|
| 2009 |
Brusco A, Tagliaferro P, Saez T, Onaivi ES. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse (New York, N.Y.). 62: 944-9. PMID 18798269 DOI: 10.1002/Syn.20569 |
0.37 |
|
| 2008 |
Brusco A, Tagliaferro PA, Saez T, Onaivi ES. Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Annals of the New York Academy of Sciences. 1139: 450-7. PMID 18991892 DOI: 10.1196/Annals.1432.037 |
0.414 |
|
| Show low-probability matches. |